Design and Synthesis of Novel Cyclooxygenase??1 Inhibitors as Analgesics: 5??Amino??2??ethoxy??N??(substituted??phenyl) benzamides

…, K Motoshima, A Tai, F Yazama, H Kakuta

Index: Fukai, Ryosuke; Zheng, Xiaoxia; Motoshima, Kazunori; Tai, Akihiro; Yazama, Futoshi; Kakuta, Hiroki ChemMedChem, 2011 , vol. 6, # 3 p. 550 - 560

Full Text: HTML

Citation Number: 3

Abstract

Abstract We previously found that N-(4-aminophenyl)-4-trifluoromethylbenzamide (TFAP), a COX-1 inhibitor, exhibits an analgesic effect without causing gastric damage. Unfortunately, TFAP causes reddish purple coloration of urine, and its analgesic effect is less potent than that of indomethacin. Herein we describe our study focusing on the development of 4-and 5- amino-2-alkoxy-N-phenylbenzamide scaffolds, designed on the basis of the structures of ...

Related Articles:

Mizoroki–Heck Reactions with 4??Phenoldiazonium Salts

[Schmidt, Bernd; Hoelter, Frank; Berger, Rene; Jessel, Soenke Advanced Synthesis and Catalysis, 2010 , vol. 352, # 14-15 p. 2463 - 2473]

(S)-N-[(1-ethyl-2-pyrrolidinyl) methyl]-5-[125I] iodo-2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors

[Paulis, Tomas de; Janowsky, Aaron; Kessler, Robert M.; Clanton, Jeffrey A.; Smith, Howard E. Journal of Medicinal Chemistry, 1988 , vol. 31, # 10 p. 2027 - 2033]

Strategic studies in the syntheses of novel 6, 7-substituted quinolones and 7-or 6-substituted 1, 6-and 1, 7-naphthyridones

[Morgentin, Remy; Pasquet, Georges; Boutron, Pascal; Jung, Frederic; Lamorlette, Maryannick; Maudet, Mickael; Ple, Patrick Tetrahedron, 2008 , vol. 64, # 12 p. 2772 - 2782]

Synthesis and neuroleptic activity of N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxy-5-sulfonamidobenzamides

[Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1137 - 1141]

More Articles...